SCHEMBL22161389

SCHEMBL22161389

O=C(CCc1c(-c2ccc(F)cc2)[nH]c2ccc(Cl)cc12)NC1CCNC1=O

nearest known ligand 0.86

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
APOL1 O14791 18/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22747543 0.93 APOL1 (1.00) APOL1
SCHEMBL22160301 0.93 APOL1 (1.00) APOL1
SCHEMBL22160157 0.93 APOL1 (1.00) APOL1
SCHEMBL22160153 0.91 APOL1 (0.71) APOL1
SCHEMBL22159647 0.90 APOL1 (0.88) APOL1
SCHEMBL22160127 0.88 APOL1 (0.84) APOL1
SCHEMBL22161154 0.88 APOL1 (1.00) APOL1
SCHEMBL22161047 0.88 APOL1 (1.00) APOL1
SCHEMBL24907189 0.87 APOL1 (0.89) APOL1
SCHEMBL22160154 0.87 APOL1 (0.89) APOL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020131807-A1 INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2020-06-25 WO disclosed